AVANDIA
- Product NDC
- 0173-0861
- 11-digit product format
- 001730861
- Labeler code
- 0173
- Product ID
- 0173-0861_4b7ec529-e57b-4115-b561-235bee3790dc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rosiglitazone maleate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- GlaxoSmithKline LLC
- Application
- NDA021071
- Marketing category
- NDA
- Marketing start
- 2011-05-25
- Marketing end
- 2021-09-30
- Substance
- ROSIGLITAZONE MALEATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0173-0861-18 | 00173086118 | 60 TABLET, FILM COATED in 1 BOTTLE (0173-0861-18) | 2011-05-25 | 2021-09-30 | No | No | Current |